Preferential inhibition of terminal deoxynucleotidyltransferase activity among deoxyribonucleic acid polymerase activities of leukemic and normal cells by geldanamycin, streptoval C, streptovarone, and dapmavarone.
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D002478:Cells, Cultured; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000201:enzymology; D008214:Lymphocytes / Q000201:enzymology; D009284:Naphthols / Q000494:pharmacology; D019384:Nucleic Acid Synthesis Inhibitors; D011809:Quinones / Q000494:pharmacology; D013310:Streptovaricin / Q000494:pharmacology* / Q000031:analogs & derivatives
D000903:Antibiotics, Antineoplastic; D009284:Naphthols; D019384:Nucleic Acid Synthesis Inhibitors; D011809:Quinones; D013310:Streptovaricin; C017174:dapmavarone; C017728:streptovarone; C017727:streptoval C; D004254:DNA Nucleotidyltransferases